Gara Jalqabaatti › Idiopathic Thrombocytopenic Purpura
Qorannoo klinikaalii Idiopathic Thrombocytopenic Purpura Ameerikaa Keessatti hirmaatuu
Qorannoo 17 Idiopathic Thrombocytopenic Purpura f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Los Angeles, CAQorannoo 7
- Washington, DCQorannoo 6
- Boston, MAQorannoo 6
- Greenville, NCQorannoo 6
- The Bronx, NYQorannoo 5
- Seattle, WAQorannoo 4
- Durham, NCQorannoo 4
- Houston, TXQorannoo 4
- Portland, ORQorannoo 4
- Rochester, MNQorannoo 4
- Kansas City, MOQorannoo 3
- Cleveland, OHQorannoo 3
- Cedar Rapids, IAQorannoo 3
- Philadelphia, PAQorannoo 3
- New Haven, CTQorannoo 3
- New Orleans, LAQorannoo 3
Naannoon
- ArkansasQorannoo 3
- CaliforniaQorannoo 10
- ConnecticutQorannoo 3
- Distaarikii KoloombiyaaQorannoo 6
- FloridaQorannoo 3
- IllinoisQorannoo 4
- IowaQorannoo 3
- LouisianaQorannoo 4
- MassachusettsQorannoo 6
- MichiganQorannoo 3
- MinnesotaQorannoo 5
- MissouriQorannoo 3
- New JerseyQorannoo 4
- New YorkQorannoo 7
- North CarolinaQorannoo 7
- OhioQorannoo 3
- OregonQorannoo 4
- PennsylvaniaQorannoo 3
- TexasQorannoo 4
- VirginiaQorannoo 4
- WashingtonQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07421167A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07786077A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06721013Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07549698A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07700238Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07095127Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06948318OM336 in Autoimmune Cytopenias
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07007962Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT05070845A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Cam-2026 · NCT06544499Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04323748Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Gur-2025 · NCT06817395Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.